Legal Representation
Attorney
Monica Riva Talley
USPTO Deadlines
Application History
25 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 13, 2025 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Jan 13, 2025 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Apr 3, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 2, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 2, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Apr 2, 2024 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Oct 26, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 24, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 24, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Oct 24, 2023 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Apr 17, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Apr 17, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Apr 17, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Apr 7, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 5, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Apr 5, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Apr 5, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 13, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 18, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 18, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 28, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 12, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 7, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 4, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 3, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Discovery, research, development, engineering, and testing of pharmaceuticals and substances, namely, functional molecules that promote binding to immune cells and disease cells, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders
Classification
International Classes
042